ACR 2022 Tweet by Eric Dein

Tweet
Eric Dein @ericdeinmd Nov 12, 2022
View on
Year in Review #ACR22
IVIG received FDA approval for adult dermatomyositis, shows benefit versus placebo
First approved Rx for inflammatory myositis
⁦@RheumNow⁩
Image from Eric Dein’s tweet
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

Topics

×